Orthostatic Hypotension

European Handbook of Neurological Management: Second Edition

Volumn 1, Issue , 2010, Pages 469-475

  Lahrmann, H ^a   Cortelli, P ^b   Hilz, M ^c   Mathias, C J ^d,e,f   Struhal, W ^g   Tassinari, M ^b  

^a KAISER FRANZ JOSEF HOSPITAL   (Austria)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^d ST MARY S HOSPITAL   (United Kingdom)

^e NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^f UNIVERSITY COLLEGE LONDON   (United Kingdom)

^g KEPLER UNIVERSITY HOSPITAL   (Austria)

Author keywords

Dihydroxyphenylserine (DOPS), a prodrug converted by dopadecarboxylase to noradrenaline; Elastic stockings and abdominal compression bands reducing venous pooling, effective; Electronic search strategies using databases, as Cochrane library, MEDLINE, Pub Med; Midodrine, a prodrug with active metabolite, desglymidodrine; Octreotide Thesomatostatin analogue inhibiting release of gastrointestinal peptides, having vasodilatatory properties; Orthostatic (postural) hypotension (OH), frequent cause of syncope contributing to morbidity, disability and even death; Orthostatic hypotension; Orthostatic hypotension, an under diagnosed disorder; Patients, advised to move to head up position slowly sitting on the edge of the bed for some minutes after recumbence; Supine hypertension, being a problem from medication or as part of the disease

Indexed keywords

EID: 84879102585     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444328394.ch33     Document Type: Chapter

References (53)

1. Mathias CJ. Autonomic diseases: clinical features and laboratory evaluation. J Neurol Neurosurg Psychiatry 2003; 74(Suppl. 3): iii31-41.
2. Low PA. Prevalence of orthostatic hypotension. Clin Auton Res 2008; 18(Suppl. 1): 8-13.
3. Senard JM, Brefel-Courbon C, Rascol O, Montastruc JL. Orthostatic hypotension in patients with Parkinson's disease: pathophysiology and management. Drugs Aging 2001; 18: 495-505.
4. Arbogast SD, Alshekhlee A, Hussain Z, McNeeley K, Chelimsky TC. Hypotension unawareness in profound orthostatic hypotension. Am J Med 2009; 122(6): 574-80.
5. Schatz IJ, Bannister R, Freeman RL, et al. Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 1996; 46: 1470.
6. Brainin M, Barnes M, Baron JC, et al. Guidance for the preparation of neurological management guidelines by EFNS scientific task forces-revised recommendations 2004. Eur J Neurol 2004; 11: 577-81.
7. Lahrmann H, Magnifico F, Haensch CA, Cortelli P. Autonomic nervous system laboratories: a European survey. Eur J Neurol 2005; 12: 375-9.
8. Mathias CJ, Bannister R. Investigation of autonomic disorders. In: Mathias CJ, Bannister R (eds) Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System, 4th edn. Oxford: Oxford Univ. Press, 2002; pp. 169-95.
9. Ravits JM. AAEM minimonograph #48: autonomic nervous system testing. Muscle Nerve 1997; 20: 919-37.
10. Chandler MP, Mathias CJ. Haemodynamic responses during head-up tilt and tilt reversal in two groups with chronic autonomic failure: pure autonomic failure and multiple system atrophy. J Neurol 2002; 249: 542-8.
11. Brignole M, Alboni P, Benditt D, et al. Guidelines on management (diagnosis and treatment) of syncope. Eur Heart J 2001; 22: 1256-306.
12. Mathias CJ, Fosbraey P, da Costa DF, Thornley A, Bannister R. The effect of desmopressin on nocturnal polyuria, overnight weight loss, and morning postural hypotension in patients with autonomic failure. Br Med J (Clin Res Ed) 1986; 293: 353-4.
13. Bouvette CM, McPhee BR, Opfer-Gehrking TL, Low PA. Role of physical countermaneuvers in the management of orthostatic hypotension: efficacy and biofeedback augmentation. Mayo Clin Proc 1996; 71: 847-53.
14. ten Harkel AD, van Lieshout JJ, Wieling W. Effects of leg muscle pumping and tensing on orthostatic arterial pressure: a study in normal subjects and patients with autonomic failure. Clin Sci (Lond) 1994; 87: 553-8.
15. Wieling W, van Lieshout JJ, van Leeuwen AM. Physical manoeuvres that reduce postural hypotension in autonomic failure. Clin Auton Res 1993; 3: 57-65.
16. Smit AA, Wieling W, Opfer-Gehrking TL, Emmerik-Levelt HM, Low PA. Patients'choice of portable folding chairs to reduce symptoms of orthostatic hypotension. Clin Auton Res 1999; 9: 341-4.
17. van Dijk N, de Bruin IG, Gisolf J, et al. Hemodynamic effects of leg crossing and skeletal muscle tensing during free standing in patients with vasovagal syncope. J Appl Physiol 2005; 98(2): 584-90.
18. Denq JC, Opfer-Gehrking TL, Giuliani M, Felten J, Convertino VA, Low PA. Efficacy of compression of different capacitance beds in the amelioration of orthostatic hypotension. Clin Auton Res 1997; 7: 321-6.
19. Tanaka H, Yamaguchi H, Tamai H. Treatment of orthostatic intolerance with infiatable abdominal band. Lancet 1997; 349: 175.
20. van Lieshout JJ, ten Harkel AD, Wieling W. Fludrocortisone and sleeping in the head-up position limit the postural decrease in cardiac output in autonomic failure. Clin Auton Res 2000; 10: 35-42.
21. Mathias CJ, Young TM. Water drinking in the management of orthostatic intolerance due to orthostatic hypotension, vasovagal syncope and postural tachycardia syndrom. Eur J Neurol 2004; 11: 613-9.
22. Sahul ZH, Trusty JM, Erickson M, Low PA, Shen WK. Pacing does not improve hypotension in patients with severe orthostatic hypotension-a prospective randomized cross-over pilot study. Clin Auton Res 2004; 14: 255-8.
23. Campbell IW, Ewing DJ, Clarke BF. 9-Alpha-fiuorohydrocortisone in the treatment of postural hypotension in diabetic autonomic neuropathy. Diabetes 1975; 24: 381-4.
24. Hoehn MM. Levodopa-induced postural hypotension. Treatment with fiudrocortisone. Arch Neurol 1975; 32: 50-1.
25. Schatz IJ, Miller MJ, Frame B. Corticosteroids in the management of orthostatic hypotension. Cardiology 1976; 61(Suppl. 1): 280-9.
26. Wright RA, Kaufmann HC, Perera R, et al. A double-blind, dose response study of midodrine in neurogenic orthostatic hypotension. Neurology 1998; 51: 120-4.
27. Jankovic J, Gilden JL, Hiner BC, et al. Neurogenic orthostatic hypotension: a double-blind, placebo-controlled study with midodrine. Am J Med 1993; 95: 38-48.
28. Low PA, Gilden JL, Freeman R, Sheng KN, McElligott MA. Efficacy of midodrine vs placebo in neurogenic orthostatic hypotension: a randomized, double-blind multicenter study. JAMA 1997; 277: 1046-51.
29. Fouad-Tarazi FM, Okabe M, Goren H. Alpha sympathomimetic treatment of autonomic insufficiency with orthostatic hypotension. Am J Med 1995; 99: 604-10.
30. Schrage WG, Eisenach JH, Dinenno FA, et al. Effects of midodrine on exercise-induced hypotension and blood pressure recovery in autonomic failure. J Appl Physiol 2004; 97: 1978-84.
31. Kaufmann H, Brannan T, Krakoff L, Yahr MD, Mandeli J. Treatment of orthostatic hypotension due to autonomic failure with a peripheral alpha-adrenergic agonist (midodrine). Neurology 1988; 38: 951-6.
32. McClellan KJ, Wiseman LR, Wilde MI. Midodrine: a review of its therapeutic use in the management of orthostatic hypotension. Drugs Aging 1998; 12: 76-86.
33. Akizawa T, Koshikawa S, Iida N, et al. Clinical effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients. Nephron 2002; 90: 384-90.
34. Iida N, Koshikawa S, Akizawa T, et al. Effects of L-threo-3,4-dihydroxyphenylserine on orthostatic hypotension in hemodialysis patients. Am J Nephrol 2002; 22: 338-46.
35. Carvalho MJ, van den Meiracker AH, Boomsma F, et al. Improved orthostatic tolerance in familial amyloidotic polyneuropathy with unnatural noradrenaline precursor L-threo-3,4-dihydroxyphenylserine. J Auton Nerv Syst 1997; 62: 63-71.
36. Freeman R, Landsberg L, Young J. The treatment of neurogenic orthostatic hypotension with 3,4-DL-threodihydroxyphenylserine: a randomized, placebo-controlled, crossover trial. Neurology 1999; 53: 2151-7.
37. Kaufmann H, Saadia D, Voustianiouk A, et al. Norepinephrine precursor therapy in neurogenic orthostatic hypotension. Circulation 2003; 108: 724-8.
38. Mathias CJ, Senard JM, Braune S, et al. L-theo-dihydroxphenylserine (L-threo-DOPS, droxidopa) in the management of neurogenic orthostatic hypotension: a multi-national, multi-centre, dose-ranging study in multiple system atrophy and pure autonomic failure. Clin Auton Res 2001; 11: 235-42.
39. Alam M, Smith G, Bleasdale-Barr K, Pavitt DV, Mathias CJ. Effects of the peptide release inhibitor, octreotide, on daytime hypotension and on nocturnal hypertension in primary autonomic failure. J Hypertens 1995; 13: 1664-9.
40. Bordet R, Benhadjali J, Libersa C, Destee A. Octreotide in the management of orthostatic hypotension in multiple system atrophy: pilot trial of chronic administration. Clin Neuropharmacol 1994; 17: 380-3.
41. Bordet R, Benhadjali J, Destee A, Belabbas A, Libersa C. Octreotide effects on orthostatic hypotension in patients with multiple system atrophy: a controlled study of acute administration. Clin Neuropharmacol 1995; 18: 83-9.
42. Hoeldtke RD, Horvath GG, Bryner KD, Hobbs GR. Treatment of orthostatic hypotension with midodrine and octreotide. J Clin Endocrinol Metab 1998; 83: 339-43.
43. Jordan J, Shannon JR, Biaggioni I, Norman R, Black BK, Robertson D. Contrasting actions of pressor agents in severe autonomic failure. Am J Med 1998; 105: 116-24.
44. Conte JJ, Fournie GJ, Maurette MH. Dihydroergotamine: an effective treatment for postural hypotension due to antihypertensive drugs (ganglion-blocking agents excepted). Cardiology 1976; 61(Suppl. 1): 342-9.
45. Lubke KO. A controlled study with Dihydergot on patients with orthostatic dysregulation. Cardiology 1976; 61(Suppl. 1): 333-41.
46. Victor RG, Talman WT. Comparative effects of clonidine and dihydroergotamine on venomotor tone and orthostatic tolerance in patients with severe hypoadrenergic orthostatic hypotension. Am J Med 2002; 112: 361-8.
47. Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993; 329: 611-5.
48. Biaggioni I, Robertson D, Krantz S, Jones M, Haile V. The anemia of primary autonomic failure and its reversal with recombinant erythropoietin. Ann Intern Med 1994; 121: 181-6.
49. Perera R, Isola L, Kaufmann H. Effect of recombinant erythropoietin on anemia and orthostatic hypotension in primary autonomic failure. Clin Auton Res 1995; 5: 211-3.
50. Beirão I, Lobato L, Moreira L, et al. Long-term treatment of anemia with recombinant human erythropoietin in familial amyloidosis TTR V30M. Amyloid 2008; 15(3): 205-9.
51. Kochar MS, Itskovitz HD. Treatment of idiopathic orthostatic hypotension (Shy-Drager syndrome) with indomethacin. Lancet 1978; 1: 1011-4.
52. Singer W, Opfer-Gehrking TL, McPhee BR, Hilz MJ, Bharucha AE, Low PA. Acetylcholinesterase inhibition: a novel approach in the treatment of neurogenic orthostatic hypotension. J Neurol Neurosurg Psychiatry 2003; 74: 1294-8.
53. Singer W, Sandroni P, Opfer-Gehrking TL, et al. Pyridostigmine treatment trial in neurogenic orthostatic hypotension. Arch Neurol 2006; 63(4): 513-8.